The Future of Diagnostics is Here.
Rapid Molecular Multiomics: On-Site, On-Demand, On-Hand.
Molomix Bioscience is revolutionising diagnostics by delivering the world’s most advanced molecular and multiomic platforms directly to the point of care. We are eliminating the delays, costs, and risks of the traditional laboratory model.
The Centralised Lab is Broken. Your Work Shouldn’t Be.
For too long, critical diagnostics have been constrained by an outdated, centralised model. We understand the frustrations because we’ve seen them first hand.
The Delays
Critical samples are shipped across the country, waiting in queues for weeks. Clinicians are forced to make decisions with incomplete information, and patient outcomes are compromised.
The Costs
The high capital expenditure required for sequencing and diagnostic equipment puts innovation out of reach for all but the largest institutions, stifling research and creating health inequalities.
The Risks
Every step in the manual, off-site process—from sample transport to manual pipetting—introduces a risk of contamination, human error, or sample loss, undermining the integrity of your results.
Our Solution: Diagnostics as a Service
Molomix Bioscience offers a complete, end-to-end solution through a simple subscription model. We eliminate the barriers to innovation by providing everything you need to bring world-class diagnostics on-site.
What’s Included:
- The Platform: Your choice of our revolutionary SiGenex-powered sequencing or molecular diagnostic platforms, installed in your facility.
- Consumables: A reliable, automated supply of all necessary cartridges and reagents, delivered before you need them.
- Training: Comprehensive, hands-on training for your team from our expert geneticists and technical specialists.
- Support: Ongoing remote and on-site support to ensure maximum uptime and optimal performance.
All with zero capital expenditure and a predictable monthly operational cost.
Technology That Delivers Clarity
The SiGenex Sequencing Platform
A proprietary “Lab-on-a-Chip” platform that fully automates the entire laboratory process. It integrates AI-driven sample processing, automated sequencing, and advanced bioinformatics to deliver rapid, actionable genomic insights directly at the point of care.
Ideal for: Liquid Biopsy, Cancer Sequencing, Companion Testing, and Population Health Studies.
The Molecular Diagnostics Platform (MDP)
A versatile platform for on-demand pathogen and infectious disease detection. By automating and accelerating complex molecular workflows, it delivers definitive results in as little as 15 minutes, empowering rapid clinical and operational decisions.
Ideal for: Hospital Infection Control, Food Safety Testing, and Veterinary Diagnostics.
Advancing Diagnostics Across Every Sector
Our platforms are designed to bring speed, accuracy, and efficiency to a wide range of critical applications.
Clinical
Diagnostics
Empowering clinicians in oncology, haematology, and infectious disease with rapid, on-site results.
Pharmaceutical Research
Accelerating drug discovery and clinical trials with on-demand companion testing and biomarker analysis.
Applied
Markets
Ensuring safety and integrity in food production, veterinary health, and forensic investigation.
Our Vision
“To revolutionise personalised healthcare across the UK and Europe by making sophisticated, innovative, and truly revolutionary molecular and multiomic diagnostic and analysis technologies affordable and accessible. We are personally committed to fighting cancer and believe that our innovative approach will lead to significant advancements in healthcare.”
Latest Articles
Quickly browse the latest news, read in-depth articles, and case studies to get the full story.